Sumo Medexim Limited
About Sumo Medexim Limited
Data last updated:
Sumo Medexim Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the diversified financial services segment of the financial services sector. It was incorporated on 15 May 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1995PLC088349. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹43.5 Lakh. It is led by directors including Shilpa Sanjay Sanghavi and Sanjay Manharlal Sanghavi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 707 Marathon Icon Marathon Nextgen Compound Opp Peninsula Corporate Park, Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.16 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹34.08 Lakh (net margin 94.3%) and EBITDA of ₹35.22 Lakh (EBITDA margin 97.4%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 9% over five years.
As per MCA filings, the company has open charges of ₹103.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sumo Medexim Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address707 Marathon Icon Marathon Nextgen Compound Opp Peninsula Corporate Park Lower Parel, West, Mumbai, Maharashtra, India – 400013
- IndustryFinancial Services, Diversified Financial Services
To see the full contact details of Sumo Medexim Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sumo Medexim Limited
FY 2025 filings availableSumo Medexim Limited reported revenue of ₹36.16 Lakh (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 2% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 9%. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35.22 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 97.4% | ||||
| Net Profit Margin | 94.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sumo Medexim Limited, buy the company report.
Board of directors of Sumo Medexim Limited
Sumo Medexim has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Het Sanjay Sanghavi Also directs: Sansula International LLP, Sansula Pharmaceuticals Private Limited | Additional Director | 15 Apr 2024 | 2 Years 6 Months | Current |
| Shilpa Sanjay Sanghavi | Director | 31 Jan 2012 | 14 Years 8 Months | Current |
| Sanjay Manharlal Sanghavi | Director | 15 May 1995 | 31 Years 5 Months | Current |
Peer comparison
Sumo Medexim Limited is compared with the 10 companies closest to it by revenue in the BFSI industry (Other Financial Services), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Utsav Business Solutions Private Limited | ₹36.2 Lakh (FY 2025) | 13.0% | New Delhi, Delhi, India | |||
| Ganapati Conbuild Private Limited | ₹36.2 Lakh (FY 2025) | 640.0% | Kolkata, West Bengal, India | |||
| Preeti Tradecom Private Limited | ₹36.18 Lakh (FY 2023) | 15.0% | Kolkata, West Bengal, India | |||
| Sheth and Sons Finance Limited | ₹36.18 Lakh (FY 2024) | 10.0% | Mumbai, Maharashtra, India | |||
| Neuf Management Consultants Private Limited | ₹36.16 Lakh (FY 2024) | 7.0% | Navi Mumbai, Maharashtra, India | |||
| Sumo Medexim Limitedthis company | ₹36.16 Lakh (FY 2025) | ₹34.08 Lakh | 94.3% | 2.0% | Mumbai, Maharashtra, India | |
| Trigon Investments and Trading Private Limited | ₹36.13 Lakh (FY 2024) | 1033.0% | New Delhi, Delhi, India | |||
| Rohit Vyapaar Private Limited | ₹36.12 Lakh (FY 2025) | 7.0% | Kolkata, West Bengal, India | |||
| Sarda Steel and Tools Private Limited | ₹36.11 Lakh (FY 2024) | 292.0% | Bangalore, Karnataka, India | |||
| Balasur Cold Storage Co Private Limited | ₹36.11 Lakh (FY 2025) | -93.0% | Kolkata, West Bengal, India | |||
| Agvesto India Imf Private Limited | ₹36.1 Lakh (FY 2025) | 85.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Sumo Medexim Limited, buy the company report.
Auditor
Sumo Medexim Limited is audited by JMT & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JMT & ASSOCIATES | FY 2023 | 104167W |
Shareholding
The shareholding of Sumo Medexim Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sumo Medexim Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Mar 2020 | 100348186 | Others | ₹90.5 Cr | Open | |
| 01 Jun 2011 | 10291016 | Reliance Home Finance Private Limited | ₹13 Cr | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Sumo Medexim Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sumo Medexim Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sumo Medexim has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Sumo Medexim Limited, buy the company report.
Recent activity
Sumo Medexim Limited has 7 board changes on record since 1995: 3 appointments and 4 cessations. The latest: Het Sanjay Sanghavi was appointed as Additional Director on 15 Apr 2024.
Frequently asked questions
Sumo Medexim is an active public limited company based in Mumbai, Maharashtra, India. The company works in diversified financial services, within the financial services industry. It was incorporated on 15 May 1995 (31+ years old) and is registered under CIN U24239MH1995PLC088349.
Sumo Medexim has 3 current directors:
- Het Sanjay Sanghavi - Additional Director
- Shilpa Sanjay Sanghavi - Director
- Sanjay Manharlal Sanghavi - Director
The latest financial statements of Sumo Medexim on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Sumo Medexim has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Sumo Medexim is U24239MH1995PLC088349. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sumo Medexim was incorporated on 15 May 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sumo Medexim by revenue are Utsav Business Solutions Private Limited, Ganapati Conbuild Private Limited, Preeti Tradecom Private Limited, Sheth and Sons Finance Limited, Neuf Management Consultants Private Limited and 5 more, all in the BFSI industry (Other Financial Services).
Het Sanjay Sanghavi was appointed as Additional Director on 15 Apr 2024. Gautam Chandrashekhar Mishra ceased to be Director on 31 Jan 2012. Shilpa Sanjay Sanghavi was appointed as Director on 31 Jan 2012. Sumo Medexim has 7 board changes on record in total.
The registered office of Sumo Medexim is at 707 Marathon Icon Marathon Nextgen Compound Opp Peninsula Corporate Park Lower Parel, West, Mumbai, Maharashtra, India – 400013.
Sumo Medexim operates in the financial services industry, in the diversified financial services segment.
Sumo Medexim has open charges of ₹103.5 Cr and no satisfied charges on record as per latest MCA filings.